Dow Down 0.48% Nasdaq Down 0.02%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
364.33 Up 13.88(3.96%) 1:34PM EDT - Nasdaq Real Time Price
Prev Close:350.45
Open:366.02
Bid:364.36 x 100
Ask:364.79 x 200
1y Target Est:356.61
Beta:0.65
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:362.38 - 369.31
52wk Range:245.99 - 369.31
Volume:854,115
Avg Vol (3m):812,423
Market Cap:36.58B
P/E (ttm):104.45
EPS (ttm):3.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 3.96%36.58B
AMGNDown 1.31%104.49B
NVSUp 4.11%226.93B
RHHBYDown 0.20%247.58B

Key Statistics

Forward P/E (1 yr):29.77
P/S (ttm):14.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :10.15
Quarterly EPS Est (Sep-14) :2.58
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.61

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback